ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
15 mars 2018 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., March 15, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at the 20th Annual Superbugs & Superdrugs UK Conference
14 mars 2018 07h00 HE
|
ContraFect Corporation
YONKERS, New York, March 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at Cantor Antibiotics Summit
11 janv. 2018 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Jan. 11, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at 10th Annual Biotech Showcase
03 janv. 2018 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect to Present at the 29th Annual Piper Jaffray Healthcare Conference
15 nov. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect to Present at the 2nd Annual Superdrugs and Superbugs USA Conference
10 nov. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect Announces Third Quarter 2017 Financial Results
09 nov. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect to Present New Data on CF-301 at ID Week 2017
29 sept. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Sept. 29, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect to Present at The MicroCap Conference
28 sept. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Sept. 28, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
13 sept. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...